Gaoma therapeutics logo

Author: kreg

August undefined, 2024

WebApr 1, 2024 · Gaoma Therapeutics General Information. Description. Developer of therapeutic molecule intended to address unmet medical needs in neurological or inflammatory diseases. The company offers particular expertise in the fields of epilepsy and cognitive disorders and offers a portfolio of innovative lipids derivatives as drug … WebGAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under ...

Gaoma Therapeutics - Overview, News & Competitors - ZoomInfo

WebGAOMA Therapeutics is a biotech company established early 2024 in Lyon, France, to develop pioneering drugs for neurological and inflammatory disorders, and more specifically for epilepsy and its associated comorbidities. The original scientific project arose from the academic research group TIGER (Translational and Integrative Group in ... WebGAOMA Therapeutics 545 följare på LinkedIn. Bioactive Lipids: the Future for Breakthrough Therapeutics GAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under-exploited, whereas it plays a key role in many … brushes for table saws

GAOMA Therapeutics - Pharmaceuticals - Overview, Competitors, …

WebInvestors of Gaoma Therapeutics include Health Angels Rhone-Alpes, Angels Sante, PPRS Venture and Simba Sante. Discover the right solution for your team The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. WebDec 20, 2024 · gaoma-therapeutics.com was created on Dec 20, 2024. A website for this domain is hosted in France, according to the geolocation of its IP address 213.186.33.5. WebNov 29, 2024 · -- Lengo Therapeutics to be acquired for $250 million in cash plus $215 million in future potential payments based on the achievement of certain approval and sales-based milestones brushes for street tag

GAOMA Therapeutics BIO-Europe Spring - Informa Connect

WebWho is Gaoma Therapeutics. GAOMA is a biotech company founded in 2024 and based in Bron, close to Lyon, France. Our team is committed to transform scientific discoveries into adapted therapeutic solutions for patients. Read More. Headquarters: 59 Blvd Pinel, Bron, Auvergne-Rhone-Alpes, 69500, France. Website: WebGAOMA Therapeutics is a biotech company established early 2024 in Lyon, France, to develop pioneering drugs for neurological and inflammatory disorders, and more specifically for epilepsy and its associated comorbidities. The original scientific project arose from … examples of b2b businessesWebScientific Advisory Board. Our SAB brings together advisors at the international level, providing GAOMA with a sharp medical and scientific expertise in its fields of operations. Prof. Emilio PERUCCA. MD, PhD. Prof. Sylvain RHEIMS. MD, PhD. Prof. Yusuf HANNUN. MD. Prof. Daniel HOYER. examples of babysitting contracts

"WebApr 1, 2024 · Alzheimer's disease is a progressive, degenerative condition causing damage to memory and behavior due to the attack on the neurons. The Alzheimer’s Disease Drugs in Development market report provides an overview of the Alzheimer’s Disease pipeline landscape. The report provides comprehensive information on the therapeutics under … " - Gaoma therapeutics logo

Gaoma therapeutics logo

WebMar 24, 2024 · The PTC Therapeutics logo is pictured on a phone screen/courtesy of SOPA Images/Getty Images. England’s National Institute for Health and Care Excellence (NICE) has recommended PTC Therapeutics’ Upstaza (eladocagene exuparvovec) for … WebCompanies like Gaoma Therapeutics include Monte Rosa Therapeutics, Remix Therapeutics, and Vigil Neuroscience. Cedilla Therapeutics . Cambridge, Massachusetts, United States 40 Contacts 1-10 employees . Biotechnology. Health Care. Therapeutics.

Did you know?

WebGAO-3-02. GAO-3-02 is a novel active ingredient developed by GAOMA Therapeutics. Thanks to its innovative mode of action, this lipid derivative represents a promising drug candidate for epilepsy. Targeting primarily the protection or restoration of cognitive functions in epilepsy, GAO-3-02 has also shown in various preclinical studies a strong ...

WebReach decision-makers at GAOMA Therapeutics. Find their phone numbers & email addresses. It’s free. - Lusha Webgaoma-tx.com : Contact Email: [email protected]: GAOMA Therapeutics industries Pharma: Headquarters Location: 59, Boulevard Pinel, Bron, Auvergne-Rhone-Alpes, 69500 FR 59, Boulevard Pinel, Bron, ... GAOMA Therapeutics Employees Size 1 …

WebApr 14, 2024 · Gaoma Therapeutics raised $1318312 on 2024-04-14 in Seed Round. Biotech Finances — 15H Biotech express jeudi : Gaoma Therapeutics, GenScript Biotech, IES Diagnostics, Imageens, Anaxago, Alchemab, Valbiotis, Kurma Diagnostics WebGAOMA Therapeutics is headquartered within the European Institute for Epilepsies (IDEE), which is located on the East hospital complex of Lyon. Home Company overview Leadership team Strategy Advisory Board Partners & Institutions Therapeutic Areas Therapeutic Approach Innovative Lipid Vectors Pipeline GAO-3-02 / GAO-11-02 News Contact.

WebAmong its portfolio of active ingredients, GAOMA Therapeutics identified a first lead compound referred to as GAO-3-02. Home Company overview Leadership team Strategy Advisory Board Partners & Institutions Therapeutic Areas Therapeutic Approach …

WebGaoma Therapeutics is a biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases. examples of bachelor\u0027s degreeWebAug 9, 2024 · In the past 5 years, W.L. has received consultancy fees from Lundbeck, AC Immune, Clexio Biosciences, and Pragma Therapeutics, and has served on the advisory board of Angelini Pharma. P.B.-F. was an employee of Grünenthal (Aachen, Germany). examples of back bondingWebGAOMA develops new therapeutic molecules, with a particular focus on epilepsy and cognitive disorders. GAO-3-02 is a novel patented active ingredient, with an innovative MoA for the treatment of epilepsy. In various preclinical PoC studies, it demonstrated its ability to limit seizures but also to protect/restore cognitive functions, both on ... examples of b2b servicesWebGaoma Therapeutics is a biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases. The company’s initial medicine candidate, GAO-3-02, is a novel proprietary active component. Gaoma Therapeutics specializes in epilepsy … examples of a writing sampleWebGaoma Therapeutics . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 22. About. Gaoma Therapeutics is actively using 22 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and SPF. examples of backcastingWebApr 14, 2024 · Gaoma Therapeutics has raised a total of €1.1M in funding over 1 round. This was a Seed round raised on Apr 14, 2024. Gaoma Therapeutics is funded by 4 investors. Angels Santé and PPRS Venture are the most recent investors. brushes for the kitchenWebGAOMA Therapeutics information. GAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under-exploited, whereas it plays a key role in many medical conditions. GAOMA has the ambition to tap into the therapeutic ... brushes for towa mini planner